Almatica Company Profile

✉ Email this page to a colleague

ALMATICA has nine approved drugs.

There are three US patents protecting ALMATICA drugs.

There are fifty-three patent family members on ALMATICA drugs in thirty-one countries and eighteen supplementary protection certificates in nine countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almatica	SERTRALINE HYDROCHLORIDE	sertraline hydrochloride	CAPSULE;ORAL	215133-002	Oct 4, 2021		RX	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Almatica	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	CAPSULE;ORAL	215428-001	Jan 31, 2022		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Almatica	ZOLPIDEM TARTRATE	zolpidem tartrate	CAPSULE;ORAL	215721-001	May 9, 2023		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Almatica	LOREEV XR	lorazepam	CAPSULE, EXTENDED RELEASE;ORAL	214826-001	Aug 27, 2021		RX	Yes	No	8,999,393	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Almatica	VENLAFAXINE BESYLATE	venlafaxine besylate	TABLET, EXTENDED RELEASE;ORAL	215429-001	Jun 29, 2022	6,717,015	⤷ Try a Trial
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-001	Jan 28, 2011	6,340,475	⤷ Try a Trial
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-002	Jan 28, 2011	7,731,989	⤷ Try a Trial
Almatica	GRALISE	gabapentin	TABLET;ORAL	022544-001	Jan 28, 2011	6,488,962	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	300 mg and 600 mg	➤ Subscribe	2011-10-31

Patent Number	Expiration Date
⤷ Try a Trial	⤷ Try a Trial

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Mexico	367364	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2007079195	⤷ Try a Trial
Japan	5421511	⤷ Try a Trial
Mexico	2015008756	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0565634	06C0030	France	⤷ Try a Trial	PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
2236132	C300714	Netherlands	⤷ Try a Trial	PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
2236132	122015000006	Germany	⤷ Try a Trial	PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
0443983	C00443983/03	Switzerland	⤷ Try a Trial	PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.